Hi Everyone!
We’re attending an advisory board on Tuesday 11th December with pharmaceutical company, Celgene to look at ways of meeting the needs of the blood cancer community around CAR-T therapies.
Whilst being aware that very few of if any of the group will have direct experience of CAR-T therapies at this point, it is really important to us that we are able to translate the impact or concerns that our community may have about the future of these therapies so that both Celgene and ourselves are able to identify needs and work together to meet these when and where appropriate.
If you have time to complete a 3 minute survey, it would be hugely appreciated! Your input will be invaluable as always!